Exact Mass: 674.3711

I07-0299

C37H54O11 (674.3666)

Cimicifugoside is a triterpenoid. CID 441913 is a natural product found in Actaea racemosa with data available.

Hymenocardine

C37H50N6O6 (674.3792)

Cimicifugoside

C37H54O11 (674.3666)

PA(12:0/20:3(8Z,11Z,14Z)-2OH(5,6))

C35H63O10P (674.4159)

PA(12:0/20:3(8Z,11Z,14Z)-2OH(5,6)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(12:0/20:3(8Z,11Z,14Z)-2OH(5,6)), in particular, consists of one chain of one dodecanoyl at the C-1 position and one chain of 5,6-dihydroxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:3(8Z,11Z,14Z)-2OH(5,6)/12:0)

C35H63O10P (674.4159)

PA(20:3(8Z,11Z,14Z)-2OH(5,6)/12:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:3(8Z,11Z,14Z)-2OH(5,6)/12:0), in particular, consists of one chain of one 5,6-dihydroxyeicosatrienoyl at the C-1 position and one chain of dodecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(i-12:0/20:3(8Z,11Z,14Z)-2OH(5,6))

C35H63O10P (674.4159)

PA(i-12:0/20:3(8Z,11Z,14Z)-2OH(5,6)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-12:0/20:3(8Z,11Z,14Z)-2OH(5,6)), in particular, consists of one chain of one 10-methylundecanoyl at the C-1 position and one chain of 5,6-dihydroxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:3(8Z,11Z,14Z)-2OH(5,6)/i-12:0)

C35H63O10P (674.4159)

PA(20:3(8Z,11Z,14Z)-2OH(5,6)/i-12:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:3(8Z,11Z,14Z)-2OH(5,6)/i-12:0), in particular, consists of one chain of one 5,6-dihydroxyeicosatrienoyl at the C-1 position and one chain of 10-methylundecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Ervahanine B

C42H50N4O4 (674.3832)

MK 7924

C34H58O13 (674.3877)

Cimiracemoside P

C37H54O11 (674.3666)

Bugbanoside D

C37H54O11 (674.3666)

Reveromycin D

C37H54O11 (674.3666)

Gambogoic acid B

C40H50O9 (674.3455)

Reveromycin C

C37H54O11 (674.3666)

Ervahanine C

C42H50N4O4 (674.3832)

Ervahanine A

C42H50N4O4 (674.3832)

Gypsin B

C36H46N6O7 (674.3428)

gaudichaudiic acid F

C40H50O9 (674.3455)

An organic heteroheptacyclic compound isolated from the bark of Indonesian Garcinia gaudichaudii and exhibits cytotoxic activity.

C30H58O16

C30H58O16 (674.3725)

reveromycin F

C37H54O11 (674.3666)

21,24-epoxy-3alpha,7alpha,21,23-tetraacetoxy-25-hydroxy-4alpha,4beta,8beta-trimethyl-14,18-cyclo-5alpha,13alpha,14alpha,17alpha-cholestane

C38H58O10 (674.403)

10,2-epoxy-11-((16S,19E)-16-methoxycarbonyl-(2alpha,7alpha)-2H-1,16-cyclo-17-nor-coryn-19-en-7-yl)-1-methyl-1H-2alpha,4-cyclo-3,4-seco-akuammilan-17-oic acid methyl ester|Pleiocorin|pleiocorine

C41H46N4O5 (674.3468)

3,21,22,28-Tetra-Ac -(3beta,16alpha,21beta,22alpha)-12-Oleanene-3,16,21,22,23,28-hexol|3,21,22,28-Tetra-Ac-12-Oleanene-3,16,21,22,23,28-hexol

C38H58O10 (674.403)

Euphoreppine A

C36H50O12 (674.3302)

cyclo(-Pro-Phe-Tyr-Pro-Gly-Leu-)|drymarin B

C36H46N6O7 (674.3428)

25(S)-22-methoxy-1beta,3beta,4beta,5beta,26-pentahydroxy-furost-26-yl O-beta-D-glucopyranoside

C34H58O13 (674.3877)

C38H58O10

C38H58O10 (674.403)

marinisporolide C

C38H58O10 (674.403)

euplexide B

C36H50O12 (674.3302)

7-hydroxy-8,14-diisobutyl-2,2,4,4,10,10,12,12-octamethyl-6-(3-methylbutyryl)-4,8,12,14-tetrahydro-5,13-dioxapentaphene-1,3,9,11-tetraone|rhodomyrtosone C

C41H54O8 (674.3818)

spinoside B

C37H54O11 (674.3666)

(4R,9beta,16alpha,24S)-25-methoxy-9,10,14-trimethyl-1,11,22-trioxo-16,24-epoxy-4,9-cyclo-9,10-secocholesta-2,5-dien-2-yl beta-D-glucopyranoside|16alpha,24alpha-epoxy-2-hydroxy-25-methoxy-3,11,22-trioxo-cucurbita-1,5-diene 2-O-beta-D-glucopyranoside|colocynthin C

C37H54O11 (674.3666)

10,2-epoxy-11-((16S,19E)-16-methoxycarbonyl-(2alpha,7alpha)-2H-1,16-cyclo-17-nor-coryn-19-en-7-yl)-1-methyl-(2beta)-1,2-dihydro-akuammilan-17-oic acid methyl ester|Pleiocralin|pleiocraline

C41H46N4O5 (674.3468)

trigoxyphin J

C38H58O10 (674.403)

mekongenine A

C41H46N4O5 (674.3468)

aphanalide F

C36H50O12 (674.3302)

3-acetyl-2-(3-hydroxy-3-methyl)glutarylanhydrocrustulinol

C38H58O10 (674.403)

xylorumphiin B

C36H50O12 (674.3302)

C33H54O14

C33H54O14 (674.3513)

3,23-O-hydroxyethylidene-3beta,23-dihydroxyurs-12,19(20)-dien-28-oic acid 28-beta-D-glucopyranosyl ester|oblonganoside A

C38H58O10 (674.403)

Fucoxanthin

C42H58O7 (674.4182)

(6Z,9Z,12Z,15Z)-octadeca-6-9-12-15-tetraenoic acid (2R)-3-[(6-O-alpha-galactopyranosyl-beta-D-galactopyranosyl)oxy]-2-hydroxypropyl ester|sarcoglycoside A

C33H54O14 (674.3513)

Euphoppin D

C36H50O12 (674.3302)

cyclo(-Leu1-Pro2-Tyr3-Phe4-Pro5-Gly6-)|gypsin B

C36H46N6O7 (674.3428)

2beta,6alpha-bis(acetyloxy)-1beta-(benzoyloxy)-4alpha-hydroxy-9alpha,13-bis[(2-methylbutanoyl)oxy]-beta-dihydroagarofuran

C36H50O12 (674.3302)

2beta,23-Dihydroxy-3-O-(4-deoxy-beta-L-threo-hex-4-enopyranosiduronic acid)-olean-12-en-28-oic acid

C38H58O10 (674.403)

vernonioside B3

C37H54O11 (674.3666)

euonydin A-3

C36H50O12 (674.3302)

C36H50O12

C36H50O12 (674.3302)

Arg Glu Lys Asp Lys

C27H50N10O10 (674.3711)

Asp Lys Arg Glu Lys

C27H50N10O10 (674.3711)

Arg Lys Asp Lys Glu

C27H50N10O10 (674.3711)

Glu Gln Lys Asp Arg

C26H46N10O11 (674.3347)

Gambogic acid B

C40H50O9 (674.3455)

C36H50O12_(1S,2S,4S,5R,6R,7S,9R,12R)-12-Acetoxy-6-(acetoxymethyl)-2-hydroxy-2,10,10-trimethyl-4,5-bis[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0~1,6~]dodec-7-yl benzoate

C36H50O12 (674.3302)

Izenamide C

C35H54N4O9 (674.3891)

Lys Arg Trp Trp

C34H46N10O5 (674.3652)

Lys Trp Arg Trp

C34H46N10O5 (674.3652)

Lys Trp Trp Arg

C34H46N10O5 (674.3652)

Gln Arg Trp Trp

C33H42N10O6 (674.3289)

Gln Trp Arg Trp

C33H42N10O6 (674.3289)

Gln Trp Trp Arg

C33H42N10O6 (674.3289)

Arg Lys Trp Trp

C34H46N10O5 (674.3652)

Arg Gln Trp Trp

C33H42N10O6 (674.3289)

Arg Trp Lys Trp

C34H46N10O5 (674.3652)

Arg Trp Gln Trp

C33H42N10O6 (674.3289)

Arg Trp Trp Lys

C34H46N10O5 (674.3652)

Arg Trp Trp Gln

C33H42N10O6 (674.3289)

Trp Lys Arg Trp

C34H46N10O5 (674.3652)

Trp Lys Trp Arg

C34H46N10O5 (674.3652)

Trp Gln Arg Trp

C33H42N10O6 (674.3289)

Trp Gln Trp Arg

C33H42N10O6 (674.3289)

Trp Arg Lys Trp

C34H46N10O5 (674.3652)

Trp Arg Gln Trp

C33H42N10O6 (674.3289)

Trp Arg Trp Lys

C34H46N10O5 (674.3652)

Trp Arg Trp Gln

C33H42N10O6 (674.3289)

Trp Trp Lys Arg

C34H46N10O5 (674.3652)

Trp Trp Gln Arg

C33H42N10O6 (674.3289)

Trp Trp Arg Lys

C34H46N10O5 (674.3652)

Trp Trp Arg Gln

C33H42N10O6 (674.3289)

DKREK

C27H50N10O10 (674.3711)

RKDKE

C27H50N10O10 (674.3711)

EQKDR

C26H46N10O11 (674.3347)

REKDK

C27H50N10O10 (674.3711)

DGMG 18:4

C33H54O14 (674.3513)

MGDG 24:4;O4

C33H54O14 (674.3513)

19-Hydroxyfucoxanthin

C42H58O7 (674.4182)

Cimicifugoside H-1

C37H54O11 (674.3666)

1,8-OCTANEDIYL-BIS(TRIBUTYLPHOSPHONIUM) DIBROMIDE

C32H70Br2P2 (674.3319)

H-Ser-Ile-Gly-Ser-Leu-Ala-Lys-OH trifluoroacetate salt

C29H54N8O10 (674.3963)

Maralixibat

C40H56N3O4S+ (674.3991)

C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor

PA(12:0/20:3(8Z,11Z,14Z)-2OH(5,6))

C35H63O10P (674.4159)

PA(20:3(8Z,11Z,14Z)-2OH(5,6)/12:0)

C35H63O10P (674.4159)

PA(i-12:0/20:3(8Z,11Z,14Z)-2OH(5,6))

C35H63O10P (674.4159)

PA(20:3(8Z,11Z,14Z)-2OH(5,6)/i-12:0)

C35H63O10P (674.4159)

Oblonganoside A

C38H58O10 (674.403)

A triterpenoid saponin thatr is the beta-D-glucopyranosyl ester of 3,23-O-hydroxyethylidene-3beta,23-dihydroxyurs-12,19(20)-dien-28-oic acid. Isolated from Ilex oblonga, it exhibits activity against TMV.

Trichodepsipeptide B

C35H54N4O9 (674.3891)

A natural product found in Trichothecium speciesMSX 51320.

leucascandrolide A congener

C36H54N2O10 (674.3778)

N-[[(3S,9S,10S)-16-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-N-methylbenzamide

C37H46N4O8 (674.3315)

N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-9-[[[(4-methoxyanilino)-oxomethyl]-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-2-phenylacetamide

C38H50N4O7 (674.3679)

4-(dimethylamino)-N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl-(4-methylphenyl)sulfonylamino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]butanamide

C35H54N4O7S (674.3713)

2-[[(2R)-2-[(E)-5,8-dioxooct-6-enoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H61NO10P+ (674.4033)

Smgdg O-18:5_6:0

C33H54O12S (674.3336)

Smgdg O-22:5_2:0

C33H54O12S (674.3336)

Smgdg O-20:5_4:0

C33H54O12S (674.3336)

Dgdg O-16:4_2:0

C33H54O14 (674.3513)

PMeOH 16:4_18:4

C38H59O8P (674.3947)

PMeOH 16:3_18:5

C38H59O8P (674.3947)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C35H63O10P (674.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C35H63O10P (674.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-undecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C35H63O10P (674.4159)

[1-hydroxy-3-[hydroxy-[3-hydroxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C35H63O10P (674.4159)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C35H63O10P (674.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C35H63O10P (674.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C35H63O10P (674.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C35H63O10P (674.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C35H63O10P (674.4159)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C35H63O10P (674.4159)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C35H63O10P (674.4159)

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoate

C38H59O8P (674.3947)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(E)-tridec-8-enoyl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C35H63O10P (674.4159)

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoate

C38H59O8P (674.3947)

[(2S)-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-undecanoyloxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C35H63O10P (674.4159)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C35H63O10P (674.4159)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C35H63O10P (674.4159)

[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C35H63O10P (674.4159)

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (10E,13E,16E)-nonadeca-10,13,16-trienoate

C38H59O8P (674.3947)

phosphatidylserine 28:2(1-)

C34H61NO10P (674.4033)

A 3-sn-phosphatidyl-L-serine(1-) in which the acyl groups at C-1 and C-2 contain 28 carbons in total and 2 double bonds.

MGDG O-29:8;O

C38H58O10 (674.403)

SMGDG O-24:5

C33H54O12S (674.3336)

SQDG 24:4

C33H54O12S (674.3336)

SQMG 25:4

C34H58O11S (674.37)

DGGA 28:7

C37H54O11 (674.3666)

MGGA 29:7

C38H58O10 (674.403)

PA O-32:4;O3

C35H63O10P (674.4159)

PA P-20:0/12:3;O3

C35H63O10P (674.4159)

PA P-20:1/12:2;O3

C35H63O10P (674.4159)

PA 14:1/18:2;O2

C35H63O10P (674.4159)

PA 20:0/12:3;O2

C35H63O10P (674.4159)

PA 20:1/11:3;O3

C34H59O11P (674.3795)

PA 20:1/12:2;O2

C35H63O10P (674.4159)

PA 22:6/12:3;O

C37H55O9P (674.3584)

PA 31:4;O3

C34H59O11P (674.3795)

PA 32:3;O2

C35H63O10P (674.4159)

PA 34:9;O

C37H55O9P (674.3584)

LPGP 24:1

C30H60O12P2 (674.356)

PG O-28:5;O2

C34H59O11P (674.3795)

PG O-29:4;O

C35H63O10P (674.4159)

PG P-16:0/13:3;O

C35H63O10P (674.4159)

PG P-16:1/12:3;O2

C34H59O11P (674.3795)

PG P-18:1/11:2;O

C35H63O10P (674.4159)

PG P-20:1/8:3;O2

C34H59O11P (674.3795)

PG 14:1/13:4;O2

C33H55O12P (674.3431)

PG 16:1/12:3;O

C34H59O11P (674.3795)

PG 18:1/9:4;O2

C33H55O12P (674.3431)

PG 18:4/9:1;O2

C33H55O12P (674.3431)

PG 20:1/8:3;O

C34H59O11P (674.3795)

PG 20:2/7:3;O2

C33H55O12P (674.3431)

PG 20:3/7:2;O2

C33H55O12P (674.3431)

PG 20:3/8:1;O

C34H59O11P (674.3795)

PG 22:2/6:2;O

C34H59O11P (674.3795)

PG 22:4/5:1;O2

C33H55O12P (674.3431)

PG 27:5;O2

C33H55O12P (674.3431)

PG 28:4;O

C34H59O11P (674.3795)

PG 11:0_18:3

C35H63O10P (674.4159)

PG 29:3

C35H63O10P (674.4159)

PG 7:0_22:3

C35H63O10P (674.4159)

LPI 24:5

C33H55O12P (674.3431)

PEth 32:9;O

C37H55O9P (674.3584)

PEth 33:8

C38H59O8P (674.3947)

PM 33:9;O

C37H55O9P (674.3584)

PM 34:8

C38H59O8P (674.3947)

ST 27:1;O8;GlcA

C33H54O14 (674.3513)

ST 28:0;O7;GlcA

C34H58O13 (674.3877)

ST 28:1;O8;Hex

C34H58O13 (674.3877)

(2r,3s,4s,5r,6r)-4-{[(2s,3r,4s,5s)-5-[(1r)-1,2-dimethoxyethyl]-3,4-dimethoxyoxolan-2-yl]oxy}-3,5-dimethoxy-2-(methoxymethyl)-6-{[(2s,3r,4s,5r)-1,2,4,5,6-pentamethoxyhexan-3-yl]oxy}oxane

C30H58O16 (674.3725)

(3s,6s,9s,15s,21s)-3-benzyl-15-[(2s)-butan-2-yl]-5,8,17,20-tetrahydroxy-6-[(4-hydroxyphenyl)methyl]-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C36H46N6O7 (674.3428)

(2z)-4-[(1s,2s,8r,15s,16s,17s,19r)-16-ethoxy-12-hydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12-tetraen-19-yl]-2-methylbut-2-enoic acid

C40H50O9 (674.3455)

(3s,6s,9s,12s,15s,18s)-15-benzyl-8,11,17-trihydroxy-6-(hydroxymethyl)-3,9-diisopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

C35H54N4O9 (674.3891)

4,12-bis(acetyloxy)-2-hydroxy-2,10,10-trimethyl-7-[(2-methylbutanoyl)oxy]-6-{[(2-methylbutanoyl)oxy]methyl}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate

C36H50O12 (674.3302)

26,37-dimethyl (10e,24e)-10,24-diethylidene-5-methyl-19-oxa-5,12,22,27-tetraazaundecacyclo[20.11.2.1⁹,¹⁵.1²¹,²⁵.0¹,²⁰.0²,¹⁸.0⁴,¹⁶.0⁶,¹².0⁶,¹⁵.0²⁰,²⁷.0²⁸,³³]heptatriaconta-2,4(16),17,28,30,32-hexaene-26,37-dicarboxylate

C41H46N4O5 (674.3468)

(1r,2r,3ar,5as,7s,9as,11as)-1-[(3r,5s)-5-[(2r,3s)-2-isopropyl-3-methyloxiran-2-yl]-2-oxooxolan-3-yl]-9a,11a-dimethyl-7-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-2-yl acetate

C37H54O11 (674.3666)

3,4-dimethoxy-6-(methoxymethyl)-2-[(1,2,4,5,6-pentamethoxyhexan-3-yl)oxy]-5-{[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy}oxane

C30H58O16 (674.3725)

4',5,6',12',17',17'-hexamethyl-4-oxo-18'-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H54O11 (674.3666)

(2r,3r,4s,5s,6r)-3,4-dimethoxy-6-(methoxymethyl)-2-{[(2s,3r,4s,5r)-1,2,4,5,6-pentamethoxyhexan-3-yl]oxy}-5-{[(2r,3r,4s,5s,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy}oxane

C30H58O16 (674.3725)

4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-13'-en-3'-yl acetate

C37H54O11 (674.3666)

(2e,4s,5s,6e,8e)-10-[(2r,5s,7r,8s)-2-[(1s,2e,4e)-5-carboxy-1-[(3-carboxypropanoyl)oxy]-4-methylpenta-2,4-dien-1-yl]-8-methyl-2-pentyl-1,6-dioxaspiro[4.5]decan-7-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

C37H54O11 (674.3666)

{[(7r,9s,10r,11s,12e,14s,15s,16z,18e,22r,25r)-3,10-dihydroxy-4,9,15,25-tetramethoxy-7,11,13,19,22-pentamethyl-20,24-dioxo-26-oxa-21-azatricyclo[19.6.0.0⁵,²⁷]heptacosa-1,3,5(27),12,16,18-hexaen-14-yl]oxy}methanimidic acid

C35H50N2O11 (674.3414)

6-(2-methoxypropan-2-yl)-2,9,11,14,19,19-hexamethyl-17-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxapentacyclo[12.8.0.0²,¹¹.0⁴,¹⁰.0¹⁵,²⁰]docosa-16,20-diene-8,13,18-trione

C37H54O11 (674.3666)

3-{[2,4-dihydroxy-6-(15-methyl-14-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadeca-3,5-dien-1-yl)phenyl]methyl}-4-hydroxy-6-methylpyran-2-one

C37H54O11 (674.3666)

(1s,2s,4s,5r,6r,7s,9r,12r)-12-(acetyloxy)-6-[(acetyloxy)methyl]-2-hydroxy-2,10,10-trimethyl-4,5-bis({[(2r)-2-methylbutanoyl]oxy})-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C36H50O12 (674.3302)

methyl 6,24-bis(acetyloxy)-22-[(acetyloxy)methyl]-10-hydroxy-2,5,14,21-tetramethyl-8-methylidene-19-oxo-17,20-dioxahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²².0¹⁶,¹⁸]tetracosane-11-carboxylate

C36H50O12 (674.3302)

13-hydroxy-2,2,4,4,8,8,10,10-octamethyl-12-(3-methylbutanoyl)-6,14-bis(2-methylpropyl)-6,14-dihydro-5,11-dioxapentaphene-1,3,7,9-tetrone

C41H54O8 (674.3818)

(1s,3r,6s,8r,12s,13r,15r,16r,17r)-15-[(2r)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-oxobutan-2-yl]-13-hydroxy-7,7,12,16-tetramethyl-14-oxo-6-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-17-yl acetate

C37H54O11 (674.3666)

3-hydroxy-4-(18-{4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}-3-(hydroxymethyl)-7,12,16-trimethyl-17-oxooctadeca-1,3,5,7,9,11,13,15-octaen-1-ylidene)-3,5,5-trimethylcyclohexyl acetate

C42H58O7 (674.4182)

(2s,3r,4s,5r)-2-[2-(6-chlorododecyl)-5-(6-chlorotetradecyl)-3-hydroxyphenoxy]oxane-3,4,5-triol

C37H64Cl2O6 (674.408)

(1s,2r,6r,7r,10r,11s,12s,14s,15s,16r,18r)-6-(furan-3-yl)-15,16-dihydroxy-12-(2-methoxy-2-oxoethyl)-7,11,13,13-tetramethyl-14-[(2-methylpropanoyl)oxy]-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-18-yl (2s)-2-methylbutanoate

C36H50O12 (674.3302)

[(2r,3r,4s,5r,6r)-6-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-pentan-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-tris(acetyloxy)oxan-2-yl]methyl acetate

C38H58O10 (674.403)

2-[(2-{[2-(3-amino-2-hydroxy-n-methyldecanamido)-1-hydroxy-4-(methylsulfanyl)butylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-hydroxyphenyl)propanoic acid

C34H50N4O8S (674.3349)

(2s,3s)-2-{[(2r,3s)-1-hydroxy-2-{[(2s)-2-hydroxy-3-methylbutanoyl]oxy}-3-methylpentylidene]amino}-n-({[(2r)-1-[(2s)-2-(methoxycarbonyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl](methyl)carbamoyl}methyl)-3-methylpentanimidic acid

C35H54N4O9 (674.3891)

4-[16-ethoxy-12-hydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4,6(11),9,12-tetraen-19-yl]-2-methylbut-2-enoic acid

C40H50O9 (674.3455)

(4r,6e,10e)-12-(2-{[(2s,3r,4r,5s,6r)-4,5-bis(acetyloxy)-6-[(acetyloxy)methyl]-3-hydroxyoxan-2-yl]oxy}-5-hydroxy-4-methylphenyl)-2,6,10-trimethyldodeca-2,6,10-trien-4-yl acetate

C36H50O12 (674.3302)

(2e,4s,5s,6e,8e)-10-[(2r,3s,6s,8s,9r)-9-butyl-8-[(1e,3e)-4-carboxy-3-methylbuta-1,3-dien-1-yl]-9-[(4-methoxy-4-oxobutanoyl)oxy]-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

C37H54O11 (674.3666)

10-[9-butyl-8-(4-carboxy-3-methylbuta-1,3-dien-1-yl)-9-[(4-methoxy-4-oxobutanoyl)oxy]-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

C37H54O11 (674.3666)

(1r,2r,3's,4'r,5s,5'r,6'r,10's,12's,16'r,18'r,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-13'-en-3'-yl acetate

C37H54O11 (674.3666)

10-(2-{5-carboxy-1-[(3-carboxypropanoyl)oxy]-4-methylpenta-2,4-dien-1-yl}-8-methyl-2-pentyl-1,6-dioxaspiro[4.5]decan-7-yl)-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

C37H54O11 (674.3666)

methyl 4,5-dihydroxy-6-{[2-hydroxy-4-(hydroxymethyl)-8a-(methoxycarbonyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-5,6-dihydro-4h-pyran-2-carboxylate

C38H58O10 (674.403)

(6r,14r)-13-hydroxy-2,2,4,4,8,8,10,10-octamethyl-12-(3-methylbutanoyl)-6,14-bis(2-methylpropyl)-6,14-dihydro-5,11-dioxapentaphene-1,3,7,9-tetrone

C41H54O8 (674.3818)

(2e,4r,5r,6e,8e)-10-[(2s,3r,6r,8r,9s)-8-[(1e,3e)-4-carboxy-3-methylbuta-1,3-dien-1-yl]-9-[(3-carboxypropanoyl)oxy]-3-methyl-9-pentyl-1,7-dioxaspiro[5.5]undecan-2-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

C37H54O11 (674.3666)

3-benzyl-5,8,17,20-tetrahydroxy-6-[(4-hydroxyphenyl)methyl]-15-(sec-butyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C36H46N6O7 (674.3428)

12-(acetyloxy)-6-[(acetyloxy)methyl]-2-hydroxy-2,10,10-trimethyl-4,5-bis[(2-methylbutanoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C36H50O12 (674.3302)

26,37-dimethyl (1r,6r,7s,9s,10e,15r,20r,21r,24e,25r,26s,37s)-10,24-diethylidene-5-methyl-19-oxa-5,12,22,27-tetraazaundecacyclo[20.11.2.1⁹,¹⁵.1²¹,²⁵.0¹,²⁰.0²,¹⁸.0⁴,¹⁶.0⁶,¹⁵.0⁷,¹².0²⁰,²⁷.0²⁸,³³]heptatriaconta-2(18),3,16,28,30,32-hexaene-26,37-dicarboxylate

C41H46N4O5 (674.3468)

(2s)-2-{[(2s)-2-{[(2s)-2-[(2s,3s)-3-amino-2-hydroxy-n-methyldecanamido]-1-hydroxy-4-(methylsulfanyl)butylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C34H50N4O8S (674.3349)

(4e,8e,12e)-4,6,8,10,12,14-hexamethyl-7,11-bis({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})hexadeca-4,8,12-trien-3-one

C34H58O13 (674.3877)

(1s,2s,4r,6s,9s,10r,11r,14r,15r)-6-(2-methoxypropan-2-yl)-2,9,11,14,19,19-hexamethyl-17-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-oxapentacyclo[12.8.0.0²,¹¹.0⁴,¹⁰.0¹⁵,²⁰]docosa-16,20-diene-8,13,18-trione

C37H54O11 (674.3666)

methyl 14-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-2,6,10,14-tetramethylhexadeca-2,6,10,15-tetraenoate

C33H54O14 (674.3513)

4,6,8,10,12,14-hexamethyl-7,11-bis({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})hexadeca-4,8,12-trien-3-one

C34H58O13 (674.3877)

(3s,6s,9s,15s,21s)-3-benzyl-5,8,17,20-tetrahydroxy-6-[(4-hydroxyphenyl)methyl]-15-(2-methylpropyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C36H46N6O7 (674.3428)

2-[(5r)-5-[(4s)-4-[(2r,4ar,6r)-6-(5-bromo-2,6,6-trimethyloxan-2-yl)-4a,6,8a-trimethyl-tetrahydro-2h-pyrano[3,2-b]pyran-2-yl]-1,4-dihydroxypentyl]-5-methyloxolan-2-yl]propan-2-yl acetate

C34H59BrO8 (674.3393)

methyl (1s,2r,5s,6r,10s,11s,14r,15s,16s,18s,21r,22s,24r)-6,24-bis(acetyloxy)-22-[(acetyloxy)methyl]-10-hydroxy-2,5,14,21-tetramethyl-8-methylidene-19-oxo-17,20-dioxahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²².0¹⁶,¹⁸]tetracosane-11-carboxylate

C36H50O12 (674.3302)

(1r,2r,3r,4s,5s,7r,8r,9r,10r,11s,13s,15r)-2,4,8-tris(acetyloxy)-16-hydroxy-5,9,12,12-tetramethyl-7-{[(2e)-2-methylbut-2-enoyl]oxy}-17-oxapentacyclo[7.6.2.0¹,¹⁰.0³,⁷.0¹¹,¹³]heptadecan-15-yl (2e)-2-methylbut-2-enoate

C36H50O12 (674.3302)

5-{[(1r,3as,7r,8r,9as,11s,11ar)-7-(acetyloxy)-1-[(1s,5s)-7,7-dimethyl-6,8-dioxabicyclo[3.2.1]octan-4-yl]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C38H58O10 (674.403)

(6r)-6-[(1r,3ar,5ar,6s,7s,9as,11s,11ar)-6-({[(3s)-4-carboxy-3-hydroxy-3-methylbutanoyl]oxy}methyl)-7,11-dihydroxy-3a,6,9a,11a-tetramethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C36H50O12 (674.3302)

6-(furan-3-yl)-15,16-dihydroxy-12-(2-methoxy-2-oxoethyl)-7,11,13,13-tetramethyl-18-[(2-methylpropanoyl)oxy]-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-14-yl 2-methylbutanoate

C36H50O12 (674.3302)

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 2-(hydroxymethyl)-4a,6a,6b,11,12,14b-hexamethyl-2h,4h,4bh,5h,6h,7h,8h,9h,10h,12ah,14h,14ah,15h,16h,16ah-piceno[3,4-d][1,3]dioxine-8a-carboxylate

C38H58O10 (674.403)

6-methyl-2-[4,7,10-tris(acetyloxy)-2-hydroxy-11a-(hydroxymethyl)-3a,6,6,9a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]hept-5-en-3-yl acetate

C38H58O10 (674.403)

6-benzyl-5,8,17,20-tetrahydroxy-3-[(4-hydroxyphenyl)methyl]-15-(2-methylpropyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C36H46N6O7 (674.3428)

methyl (1s,15r,17s,18s)-17-ethyl-6-[(1s,12r,14r,15z,18s)-15-ethylidene-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C42H50N4O4 (674.3832)

(1s,3r,6r,8r,12s,13r,15r,16r,17r)-15-[(2r)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-oxobutan-2-yl]-13-hydroxy-7,7,12,16-tetramethyl-14-oxo-6-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-17-yl acetate

C37H54O11 (674.3666)

2-({1-hydroxy-2-[(2-hydroxy-3-methylbutanoyl)oxy]-3-methylpentylidene}amino)-n-[({1-[2-(methoxycarbonyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl}(methyl)carbamoyl)methyl]-3-methylpentanimidic acid

C35H54N4O9 (674.3891)

4-{[5-(1,2-dimethoxyethyl)-3,4-dimethoxyoxolan-2-yl]oxy}-3,5-dimethoxy-2-(methoxymethyl)-6-[(1,2,4,5,6-pentamethoxyhexan-3-yl)oxy]oxane

C30H58O16 (674.3725)

5-{[7-(acetyloxy)-1-{7,7-dimethyl-6,8-dioxabicyclo[3.2.1]octan-4-yl}-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C38H58O10 (674.403)

1-[5-(2-isopropyl-3-methyloxiran-2-yl)-2-oxooxolan-3-yl]-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-2-yl acetate

C37H54O11 (674.3666)

7-(acetyloxy)-15-[2,5-bis(acetyloxy)-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-3-yl acetate

C38H58O10 (674.403)

15-[4-(3,3-dimethyloxiran-2-yl)-4-oxobutan-2-yl]-13-hydroxy-7,7,12,16-tetramethyl-14-oxo-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-17-yl acetate

C37H54O11 (674.3666)

(1r,1'r,2r,3'r,4'r,5s,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-4',5,6',12',17',17'-hexamethyl-4-oxo-18'-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-3'-yl acetate

C37H54O11 (674.3666)

(1r,1's,2r,3'r,4s,4'r,5s,5'r,6'r,10's,12's,16'r,18's,21'r)-4-hydroxy-4',5,6',12',17',17'-hexamethyl-18'-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-3,6,9'-trioxaspiro[bicyclo[3.1.0]hexane-2,8'-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan]-13'-en-3'-yl acetate

C37H54O11 (674.3666)

(2s,3r,4s,5r,6r)-3,4-dimethoxy-6-(methoxymethyl)-2-{[(2r,3r,4s,5s)-1,2,4,5,6-pentamethoxyhexan-3-yl]oxy}-5-{[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy}oxane

C30H58O16 (674.3725)

methyl (4s,5r,6r)-6-{[(2s,3r,4r,4ar,6ar,6bs,8as,12as,14ar,14br)-2-hydroxy-4-(hydroxymethyl)-8a-(methoxycarbonyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-4,5-dihydroxy-5,6-dihydro-4h-pyran-2-carboxylate

C38H58O10 (674.403)

26,37-dimethyl (10e,24e)-10,24-diethylidene-5-methyl-19-oxa-5,12,22,27-tetraazaundecacyclo[20.11.2.1⁹,¹⁵.1²¹,²⁵.0¹,²⁰.0²,¹⁸.0⁴,¹⁶.0⁶,¹⁵.0⁷,¹².0²⁰,²⁷.0²⁸,³³]heptatriaconta-2,4(16),17,28,30,32-hexaene-26,37-dicarboxylate

C41H46N4O5 (674.3468)

3-({2,4-dihydroxy-6-[(3e,5e,14r,15s)-15-methyl-14-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptadeca-3,5-dien-1-yl]phenyl}methyl)-4-hydroxy-6-methylpyran-2-one

C37H54O11 (674.3666)

methyl (1s,15r,17r,18s)-17-ethyl-6-[(1s,12r,14r,15e,18r)-15-ethylidene-18-(methoxycarbonyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraen-12-yl]-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraene-1-carboxylate

C42H50N4O4 (674.3832)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-7-(acetyloxy)-15-[(2s,3s,5r,6r)-2,5-bis(acetyloxy)-6-(2-hydroxypropan-2-yl)oxan-3-yl]-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-3-yl acetate

C38H58O10 (674.403)

3-benzyl-5,8,17,20-tetrahydroxy-6-[(4-hydroxyphenyl)methyl]-15-(2-methylpropyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C36H46N6O7 (674.3428)

(4s,6e,10e)-12-(2-{[4,5-bis(acetyloxy)-6-[(acetyloxy)methyl]-3-hydroxyoxan-2-yl]oxy}-5-hydroxy-4-methylphenyl)-2,6,10-trimethyldodeca-2,6,10-trien-4-yl acetate

C36H50O12 (674.3302)

26,37-dimethyl (1r,6r,9r,10e,15r,20r,21s,24e,25s,26s,37r)-10,24-diethylidene-5-methyl-19-oxa-5,12,22,27-tetraazaundecacyclo[20.11.2.1⁹,¹⁵.1²¹,²⁵.0¹,²⁰.0²,¹⁸.0⁴,¹⁶.0⁶,¹².0⁶,¹⁵.0²⁰,²⁷.0²⁸,³³]heptatriaconta-2,4(16),17,28,30,32-hexaene-26,37-dicarboxylate

C41H46N4O5 (674.3468)

(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-2-hydroxy-2,10,10-trimethyl-7-{[(2r)-2-methylbutanoyl]oxy}-6-({[(2r)-2-methylbutanoyl]oxy}methyl)-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate

C36H50O12 (674.3302)

[3,4-bis(acetyloxy)-6-{2-[9-(acetyloxy)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-4-hydroxy-5-methylphenoxy}-5-hydroxyoxan-2-yl]methyl acetate

C36H50O12 (674.3302)

(2e,4r,5r,6e,8e)-10-[(2s,3r,6r,8r,9s)-8-[(1e,3e)-4-carboxy-3-methylbuta-1,3-dien-1-yl]-9-[(3-carboxypropanoyl)oxy]-3-methyl-9-(3-methylbutyl)-1,7-dioxaspiro[5.5]undecan-2-yl]-5-hydroxy-4,8-dimethyldeca-2,6,8-trienoic acid

C37H54O11 (674.3666)

4-[11-ethoxy-15-hydroxy-6,6,19,23,23-pentamethyl-26-(2-methylbut-3-en-2-yl)-9,13-dioxo-2,7,24-trioxaheptacyclo[12.12.0.0³,⁸.0³,¹².0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]hexacosa-1(26),14,16(25),18-tetraen-8-yl]-2-methylbut-2-enoic acid

C40H50O9 (674.3455)

(3s,6s,9s,15s,21s)-6-benzyl-5,8,17,20-tetrahydroxy-3-[(4-hydroxyphenyl)methyl]-15-(2-methylpropyl)-1,4,7,13,16,19-hexaazatricyclo[19.3.0.0⁹,¹³]tetracosa-4,7,16,19-tetraene-2,14-dione

C36H46N6O7 (674.3428)

(3s)-5-{[(1r,3as,5ar,7r,8r,9as,11s,11ar)-7-(acetyloxy)-1-[(1r,4r,5r)-7,7-dimethyl-6,8-dioxabicyclo[3.2.1]octan-4-yl]-11-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-8-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C38H58O10 (674.403)

(1s,2r,6r,7r,10r,11s,12s,14s,15s,16r,18r)-6-(furan-3-yl)-15,16-dihydroxy-12-(2-methoxy-2-oxoethyl)-7,11,13,13-tetramethyl-18-[(2-methylpropanoyl)oxy]-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-14-yl (2s)-2-methylbutanoate

C36H50O12 (674.3302)

15-benzyl-8,11,17-trihydroxy-6-(hydroxymethyl)-3,9-diisopropyl-13-methyl-12,18-bis(2-methylpropyl)-1,4-dioxa-7,10,13,16-tetraazacyclooctadeca-7,10,16-triene-2,5,14-trione

C35H54N4O9 (674.3891)

(2s,3s)-2-[(1r,2s,3ar,4r,5ar,7s,9as,10s,11as)-4,7,10-tris(acetyloxy)-2-hydroxy-11a-(hydroxymethyl)-3a,6,6,9a-tetramethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-3-yl acetate

C38H58O10 (674.403)

(1s,3r)-3-hydroxy-4-[(3z,5e,7e,9e,11e,13e,15e)-18-[(1s,4s,6r)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-3-(hydroxymethyl)-7,12,16-trimethyl-17-oxooctadeca-1,3,5,7,9,11,13,15-octaen-1-ylidene]-3,5,5-trimethylcyclohexyl acetate

C42H58O7 (674.4182)

(2e)-4-[(3r,5r,8s,10r,11r,12s,17r,22r)-11-ethoxy-15-hydroxy-6,6,19,23,23-pentamethyl-26-(2-methylbut-3-en-2-yl)-9,13-dioxo-2,7,24-trioxaheptacyclo[12.12.0.0³,⁸.0³,¹².0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]hexacosa-1(26),14,16(25),18-tetraen-8-yl]-2-methylbut-2-enoic acid

C40H50O9 (674.3455)

(4e,6s,7r,8e,10r,11r,12e,14r)-4,6,8,10,12,14-hexamethyl-11-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadeca-4,8,12-trien-3-one

C34H58O13 (674.3877)

methyl (2e,4r,6e,10e,14s)-14-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-2,6,10,14-tetramethylhexadeca-2,6,10,15-tetraenoate

C33H54O14 (674.3513)

(6-{[9a,11a-dimethyl-1-(pentan-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-tris(acetyloxy)oxan-2-yl)methyl acetate

C38H58O10 (674.403)